| 154361-50-9 |
Capecitabine |
5'-DEOXY-5-FLUOROCYTISINE;5'-DEOXY-5-FLUORO-N-[(PENTYLOXY)CARBONYL]CYTIDINE;CAPECITABINE;RO-9-1978;pentyl [1-(3,4-dihydroxy-5-methyl-oxolan-2-yl)-5-fluoro-2-oxo-pyrimidin-4-yl]aminoformate;XELODA;Cpecitabine;5Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine, Ro-9-1978, Xeloda |
C15H22FN3O6 |
36
supplier(s)
154361-50-9 |
| 118443-89-3 |
CEFQUINOME SULFATE |
(6R,7R)-7-(((2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-8-oxo-3-(5,6,7,8-tetrahydro-1-quinoliniumylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Sulfate; (6R,7R)-7-{[(2Z)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-8-oxo-3-(5,6,7,8-tetrahydroquinolinium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate sulfate (1:1); HR 111V sulfate |
C23H26N6O9S3 |
13
supplier(s)
118443-89-3 |
| 100-66-3 |
Anisole |
Methoxybenzene; Methyl phenyl ether; ANISOL (METHOXYBENZENE); Phenol methyl ether; Phenyl methyl ether; Phenylmethylether: |
C7H8O |
4
supplier(s)
100-66-3 |
| 157283-68-6 |
Travoprost |
(+/-)-16-(M-TRIFLUOROMETHYLPHENOXY)TETRANORPROSTAGLANDIN F2; 15(S)-FLU-IPR; 15(S)-FLUPROSTENOL ISOPROPYL ESTER; (+)-9ALPHA,11ALPHA,15R-TRIHYDROXY-16-(3-(TRIFLUOROMETHYL)PHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, ISOPROPYL ESTER; 9ALPHA,11ALPHA,15S-TRIHYDROXY-16(3-(TRIFLUOROMETHYL)PHENOXY)-17,18,19,20-TETRANOR-PROSTA-5Z,13E-DIEN-1-OIC ACID, ISOPROPYL ESTER; (+)-FLUPROSTENOL ISOPROPYL ESTER; FLUPROSTENOL ISOPROPYL ESTER; FLU-IPR; 1-methylethyl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoate |
C26H35F3O6 |
17
supplier(s)
157283-68-6 |
| 148553-50-8 |
pregabalin |
3-(aminomethyl)-5-methyl-hexanoic acid; Pregablin; (3S)-3-(aminomethyl)-5-methyl-hexanoic acid; (R-)-3-isobutyl GABA; 3-isobutyl GABA; CI 1008; CI-1008; 3-(aminomethyl)-5-methyl-(3S)-Hexanoic acid; 3-(aminomethyl)-5-methyl-(S)-Lyrica; PD 144723; PD-144723; Pregabalin [USAN]; TOS-BB-0910; Pregabalin intermediate; (3R)-3-(aminomethyl)-5-methylhexanoic acid; (S)-Pregabalin |
C8H17NO2 |
27
supplier(s)
148553-50-8 |
| 153-98-0 |
Serotonin hydrochloride |
SERATONIN HYDROCHLORIDE; SEROTONIN HCL; TIMTEC-BB SBB003418; 5-HYDROXYTRYPTAMINE HCL; 5-HYDROXYTRYPTAMINE HYDROCHLORIDE; 5-HYDROXY-3-(2-AMINOETHYL)INDOLE HYDROCHLORIDE; 5-HT; 3-(2-aminoethyl)-1H-indol-5-ol hydrochloride (1:1) |
C10H13ClN2O |
8
supplier(s)
153-98-0 |
| 145108-58-3 |
DEXMEDETOMIDINE HCL |
4-[(1r)-1-(2,3-dimethylphenyl)ethyl]-3h-imidazole hydrochloride ; 4-((s)-alpha,2,3-trimethylbenzyl)imidazole monohydrochloride ; DEXMEDETOMIDINE HYDROCHLORIDE ; DEMEDETOMIDINE HCL ; Dexmedetomidine(Pilot); ; 5-[(1R)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole hydrochloride (1:1); 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole hydrochloride |
C13H17ClN2 |
15
supplier(s)
145108-58-3 |
| 148411-57-8 |
CHITOSAN OLIGOSACCHARIDE LACTATE |
CHITOSAN OLIGOSACCHARIDE LACTATE;Chitosan 2-hydroxypropanoate (ester);Chitosan lactate (ester) |
(C12H24N2O9)n |
3
supplier(s)
148411-57-8 |
| 129453-61-8 |
Fulvestrant |
(7a,17b)-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol; (7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol; (17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol |
C32H47F5O3S |
20
supplier(s)
129453-61-8 |
| 147098-20-2 |
ROSUVASTATIN CALCIUM |
Rosuvastatin Calcium; (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[N-methyl(n-methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-Heptenoic calcium; (3R,5S,6E)-7-[4-(4-fluorophenyl)-2-[methyl(methylsulfonyl)amino]-6-(propan-2-yl)pyrimidin-5-yl]-3,5-dihydroxyhept-6-enoic acid; (6E)-7-{4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl}-3,5-dihydroxyhept-6-enoic acid; calcium(-1) anion; (E)-6-[4-(4-fluorophenyl)-6-isopropyl-2-(methyl-methylsulfonyl-amino)pyrimidin-5-yl]-2,4-dihydroxy-hex-5-enoate |
C43H51F2N6O12S2 |
37
supplier(s)
147098-20-2 |
Pharma Sources Insight July 2025
